Aim: To present our experience with laparoscopic live donor nephrectomy (LLDN), evolution of the technique and analysis with respect to the cost-effective modifications. Materials and Methods: This is a retrospective review of all the LLDNs performed at our institute from January 2001 to November 2006. Few of the cost-effective modifications to the procedure include use of metallic autoclavable ports and instruments, Hem-o-lock clips for ureter, renal artery and vein, and extraction of the graft manually without use of a specimen retrieval bag. Results: From January 2001 to December 2001, 42 laparoscopy-assisted LLDNs, and since December 2001 380 LLDNs were performed, which includes 342 cases of transperitoneal and 38 cases of retroperitoneal LLDN. The mean operative time was 180 ± 45 and 192 ± 35 min, mean blood loss was 85 ± 50 and 115 ± 50 ml, warm ischemia time was 4.5 ± 2 and 3.5 ± 1.5 min in transperitoneal and retroperitoneal LLDNs, respectively. The total number of conversions was 14, with 12 in the transperitoneal group and 2 in the retroperitoneal group. Mean hospital stay was 3.14 ± 1.5 days. Recipient mean serum creatinine at days 1, 3 and 7 was 2.56 ± 0.91, 1.63 ± 0.46 and 1.72 ± 0.25, respectively. The total cost incurred by the patient at our institute for LLDN including stay in the hospital was USD 500 ± 150. Conclusion: LLDN provides all the benefits of minimally invasive therapy to the donors while preserving allograft function in the recipients. Few technical modifications can make the procedure more cost-effective for routine use.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.